Q3 2025 Earnings Call Transcript May 14, 2025 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $0.2, ...

Third Quarter 2025 Results Key Financial Results Revenue: US$18.5m (up 2.6% from ...

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during ...

Aytu BioPharma Inc (AYTU) reports significant revenue growth and operational income, despite challenges in gross margins and acquisition valuations.

Q3 2025 Management View CEO Josh Disbrow opened by stating, "Total revenue grew 32%, led by growth in both our ADHD portfolio, which was up 25%, and pediatric portfolio, which was up 77%." Disbrow ...

Net income of $4.0 million, or $0.65 and $0.21 net income per share basic and diluted, respectivelyAdjusted EBITDA1 of $3.9 millionTotal net revenue of $18.5 million up 32% year-over-yearCompany to ...

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments.

Aytu BioPharma reported a strong financial performance in Q3 FY2025, with significant revenue growth and a return to profitability. The company’s stock surged 52.6% in aftermarket trading ...

1x1 meetings will be scheduled and conducted in person on April 24, 2025, at the conference venue: Paris Hotel & Casino in Las Vegas, NV About Aytu BioPharma, Inc. (AYTU) Aytu is a pharmaceutical ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With the business potentially at an important milestone, we thought we'd take a closer look at Aytu BioPharma, Inc.'s... Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical ...